Brian R. Sloat

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

Brian R. Sloat, Michael A. Sandoval, Li Dong et al. · International Journal of Pharmaceutics · 2011 · 105 citations

Nanoparticles, Nanomedicine, Engineering +7

Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel

Nijaporn Yanasarn, Brian R. Sloat, Zhengrong Cui · International Journal of Pharmaceutics · 2009 · 96 citations · Full text

Nanoparticles, Nanomedicine, Potential Delivery System +10

Relationship between the size of nanoparticles and their adjuvant activity: Data from a study with an improved experimental design

Xinran Li, Brian R. Sloat, Nijaporn Yanasarn et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2010 · 85 citations

Nanoparticles, Nanomedicine, Engineering +8

Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles

Brian R. Sloat, Michael A. Sandoval, Andrew M. Hau et al. · Journal of Controlled Release · 2009 · 81 citations · Full text

Nanoparticles, Strong Antibody Responses, Engineering +8

EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity

Michael A. Sandoval, Brian R. Sloat, Dharmika S.P. Lansakara-P et al. · Journal of Controlled Release · 2011 · 64 citations

Nanomedicine, Therapeutic Nanomaterials, Egfr-targeted Stearoyl Gemcitabine +3